A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Director – Platform Infrastructure

Platform EngineeringConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$186.4k - $252.2k

About the Job

Requirements

  • A bachelor's degree in computer science, information technology, engineering, or a related field is required; an advanced degree is preferred.
  • 12+ years of progressive experience across enterprise infrastructure, cloud, hosting, storage, data protection, observability, automation, FinOps, or platform engineering, including 5+ years leading infrastructure engineering, architecture, cloud, technical operations, or platform teams.
  • Demonstrated experience defining and executing infrastructure, cloud, or platform transformation strategies within a complex global enterprise environment.
  • Strong technical understanding of public and hybrid cloud, compute, virtualization, operating platforms, storage, backup, disaster recovery, cyber recovery, observability, automation, identity integration, networking, and infrastructure security controls.
  • Experience establishing cloud platforms and governance, including landing zones, account structures, platform guardrails, Infrastructure as Code, automation, policy-as-code, and self-service capabilities within AWS, Azure, or comparable hyperscale environments.
  • Experience with cloud financial management, FinOps, budgeting, forecasting, capital planning, vendor management, technology investment governance, and managed service provider oversight.
  • Strong executive communication, stakeholder management, and influencing skills, with the ability to translate complex platform strategies into clear business outcomes.

Responsibilities

  • Define and execute the enterprise platform infrastructure strategy and multi-year roadmap across public cloud, on-premises hosting, storage, data protection, observability, automation, lifecycle management, and FinOps.
  • Evolve infrastructure services into a platform engineering model that delivers standardized, reusable, automated, and self-service capabilities, including Infrastructure as Code, policy-as-code, platform patterns, and architectural guardrails.
  • Own the architecture, engineering, and lifecycle of secure, resilient, and scalable hybrid cloud and on-premises platforms supporting enterprise applications, Science, Manufacturing, laboratories, facilities, data, AI, and regulated OT environments.
  • Partner with Manufacturing, Facilities, Quality, Cybersecurity, laboratory technology, automation, and OT engineering teams to align platform services with validated-state, data-integrity, change-control, security, and business-continuity requirements.
  • Set enterprise standards for availability, recoverability, observability, capacity, disaster recovery, backup, cyber recovery, technical debt management, lifecycle planning, SLOs, SLIs, and operational health measures.
  • Lead cloud financial management and FinOps practices, including tagging, allocation, budgeting, forecasting, cost transparency, optimization, unit economics, and financial accountability for cloud consumption.
  • Build and lead a high-performing infrastructure platform organization across cloud, infrastructure, storage, data protection, observability, automation, and platform engineering.
  • Govern managed service providers, cloud providers, infrastructure vendors, and technology partners while retaining internal ownership of strategy, architecture, engineering standards, and platform direction.
  • Manage operating and capital budgets, cloud consumption forecasts, modernization investments, lifecycle roadmaps, capacity plans, and vendor strategies that improve scalability, reliability, security, performance, and financial sustainability.

Desired Qualifications

  • Biotechnology, pharmaceutical, life sciences, manufacturing, or other regulated industry experience is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs